These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support. van der Lelie H; Baars JW; Rodenhuis S; van Dijk MA; de Glas-Vos CW; Thomas BL; van Oers RH; von dem Borne AE Cancer; 1995 Dec; 76(11):2338-42. PubMed ID: 8635040 [TBL] [Abstract][Full Text] [Related]
29. [An adult case of hemolytic-uremic syndrome treated with inhibitors of platelet functions (author's transl)]. Mori H Rinsho Ketsueki; 1979 Nov; 20(11):1475-81. PubMed ID: 537167 [No Abstract] [Full Text] [Related]
30. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review. Bosch T; Wendler T Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754 [TBL] [Abstract][Full Text] [Related]
31. The hemolytic uremic syndrome presenting as bilateral leg ischemia. Takino M; Anada T; Okada Y Am J Emerg Med; 1997 Jul; 15(4):365-7. PubMed ID: 9217526 [TBL] [Abstract][Full Text] [Related]
32. Digital gangrene in small cell lung cancer: response to aspirin treatment. Arrowsmith JE; Woodhead MA; Bevan DH; Nanson EM; Cummin AR Thorax; 1991 Jan; 46(1):63-4. PubMed ID: 1651564 [TBL] [Abstract][Full Text] [Related]
33. Decreased plasma fibronectin levels in children with hemolytic-uremic syndrome. Cosio FG; Eddy A; Mentser MI; Bergstein JM Am J Med; 1985 Apr; 78(4):549-54. PubMed ID: 3885728 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of thrombocytopenic thrombotic purpura]. Corte Buelga JR; Rodríguez Vicente P; García Gala JM; Alonso García AM; Martínez Revuelta E Sangre (Barc); 1997 Feb; 42(1):53-61. PubMed ID: 9229804 [No Abstract] [Full Text] [Related]
35. [The hemolytic-uremic syndrome]. Rodrigues PA; Machado J; Cardoso O; Cruz J; Carvalho F; da Costa M; Proença R Acta Med Port; 1999; 12(4-6):217-22. PubMed ID: 10481325 [TBL] [Abstract][Full Text] [Related]
36. [Postpartum hemolytic uremic syndrome: a rare entity and a treatment challenge]. Alsina Segui E; Martín Conde ML; Craver Hospital L; Fernández Giráldez E Nefrologia; 2008; 28(1):120-1. PubMed ID: 18336155 [TBL] [Abstract][Full Text] [Related]
37. Common variable immunodeficiency complicated with hemolytic uremic syndrome. Milošević B; Stojanović V; Nikolić M; Konstantinidis G; Rudić A Ups J Med Sci; 2012 Mar; 117(1):67-71. PubMed ID: 22059898 [TBL] [Abstract][Full Text] [Related]
38. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Shibagaki Y; Fujita T Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259 [TBL] [Abstract][Full Text] [Related]
39. Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: a report of a case and a review of the literature. Gardner G; Mesler D; Gitelman HJ Ren Fail; 1989; 11(2-3):133-7. PubMed ID: 2482985 [TBL] [Abstract][Full Text] [Related]
40. Secondary membranoproliferative glomerulonephritis due to hemolytic uremic syndrome: an unusual presentation. Jha V; Murthy MS; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V Ren Fail; 1998 Nov; 20(6):845-50. PubMed ID: 9834983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]